CORRESP Filing
Silexion Therapeutics Corp
Date: Sept. 9, 2025 · CIK: 0002022416 · Accession: 0001178913-25-003280
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290074
Letter
Re:
September 9, 2025
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission Division of Corporate Finance Washington, DC 20549
Silexion Therapeutics Corp
Registration Statement on Form S-1 (Registration No. 333-290074) -
Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC (“ Wainwright ”), solely acting as placement agent on a best-efforts basis in an offering pursuant to the registration statement on Form S-1 (333-290074) (the “ Registration Statement ”), hereby concurs in the request by Silexion Therapeutics Corp that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. Eastern Time on Thursday, September 11, 2025, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
Show Raw Text
CORRESP 1 filename1.htm September 9, 2025 VIA FACSIMILE AND EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance Washington, DC 20549 Re: Silexion Therapeutics Corp Registration Statement on Form S-1 (Registration No. 333-290074) - Concurrence in Acceleration Request Ladies and Gentlemen: H.C. Wainwright & Co., LLC (“ Wainwright ”), solely acting as placement agent on a best-efforts basis in an offering pursuant to the registration statement on Form S-1 (333-290074) (the “ Registration Statement ”), hereby concurs in the request by Silexion Therapeutics Corp that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. Eastern Time on Thursday, September 11, 2025, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement. Very truly yours, H.C. WAINWRIGHT & CO., LLC By: /s/ Edward D. Silvera Name: Edward D. Silvera Title: Chief Operating Officer 430 Park Avenue | New York, NY 10022 | 212.356.0500 | www.hcwco.com Member: FINRA/SIPC